Neos Therapeutics Q3 EPS $(0.04) Beats $(0.1) Estimate, Sales $17.54M Miss $17.62M Estimate

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.1) by 60 percent. This is a 90.7 percent increase over losses of $(0.43) per share from the

Benzinga · 11/08/2019 12:09

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.1) by 60 percent. This is a 90.7 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $17.54 million which missed the analyst consensus estimate of $17.62 million by 0.45 percent. This is a 40.29 percent increase over sales of $12.503 million the same period last year.